SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-10-194979
Filing Date
2010-08-23
Accepted
2010-08-23 16:09:48
Documents
5
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d10ka.htm 10-K/A 398810
2 MUDELTA DEVELOPMENT AND LICENSE AGREEMENT dex10272.htm EX-10.272 304218
3 TOPO DEVELOPMENT AND LICENSE AGREEMENT dex10274.htm EX-10.274 307252
4 CERTIFICATION OF CEO dex311.htm EX-31.1 9668
5 CERTIFICATION OF CFO dex312.htm EX-31.2 9744
  Complete submission text file 0001193125-10-194979.txt   1031127
Mailing Address 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address 929 NORTH FRONT STREET WILMINGTON NC 28401 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-27570 | Film No.: 101032653
SIC: 8731 Services-Commercial Physical & Biological Research